Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Abroad (travel likely)RecruitingPHASE2

Conditions

Liver Cancer · Antibody

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
Contact: Study coordinator (Zhenfeng Zhang, MD, PhD) · zhangzhf@gzhmu.edu.cn · +862039195966
Contact: Study coordinator (Bingjia He) · 464677938@qq.com · +862039195965
Contact: Principal Investigator (Zhenfeng Zhang, MD, PHD)

Study leads

Zhenfeng Zhang, MD, PhD
Principal Investigator
Second Affiliated Hospital of Guangzhou Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Lung Cancer · Liver Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

Colorectal Cancer · Liver Metastases · Liver Cancer

Abroad (travel likely)Recruiting

Cleveland, United States

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Liver Cancer · Liver Metastasis Colon Cancer · Kidney Cancer

Abroad (travel likely)Recruiting

Milan, Italy